Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Mantle cell lymphoma refractory
ADR ID BADD_A07396
ADR Hierarchy
01      Blood and lymphatic system disorders
01.15      Lymphomas non-Hodgkin's B-cell
01.15.05      Mantle cell lymphomas
01.15.05.003      Mantle cell lymphoma refractory
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.28      Lymphomas non-Hodgkin's B-cell
16.28.05      Mantle cell lymphomas
16.28.05.003      Mantle cell lymphoma refractory
Description Not Available
MedDRA Code 10026801
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Centrocytic (mantle cell) lymphoma (Kiel classification) refractory | Mantle cell lymphoma refractory | Mantle zone lymphoma refractory | Small cleaved cell diffuse or nodular rarely diffuse mixed or large cleaved cell refractory | Small cleaved follicular cell lymphoma (Mantle cell lymphoma) refractory
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01253Lenalidomide0.000241%
BADD_D02345Venetoclax0.000112%
The 1th Page    1    Total 1 Pages